In recent years, the pharmaceutical industry has increasingly turned to real-world evidence (RWE) to enhance the design of clinical trials and improve patient outcomes. Unlike traditional clinical trials, which are conducted in highly controlled environments, RWE utilizes data from real-life settings to provide a more accurate picture of how treatments perform in everyday situations. By […]
ABBO News Covers ImmunityBio’s Promising Clinical Trial Results and Stock Surge
ABBO News has recently covered a really exciting news on ImmunityBio. ImmunityBio is a biotechnology company that focuses on developing innovative immunotherapies. Edward Cooke the financial analyst wrote that ImmunityBio’s stock (NASDAQ: IBRX) has experienced a remarkable shift of over 30% in the early trading hours on Monday, April 29th, 2024. This biggest change and […]